These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4826493)

  • 21. [Activation of protective reactions of the organism in malignant growths].
    Balitskiĭ KP; Struk VI
    Zh Eksp Klin Med; 1968; 8(2):3-8. PubMed ID: 5759432
    [No Abstract]   [Full Text] [Related]  

  • 22. [Autochtonous animal tumors as test models for cancer chemotherapy].
    Schmähl D
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1970 Jun; 40(6):173-5. PubMed ID: 5468737
    [No Abstract]   [Full Text] [Related]  

  • 23. Chemotherapeutic and hormonal considerations of the Nb rat prostatic adenocarcinoma model.
    Drago JR; Goldman LB; Gershwin ME
    Prog Clin Biol Res; 1980; 37():325-63. PubMed ID: 7384092
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical Mel B, resistance in Rhodesian sleeping sickness.
    Ogada T
    East Afr Med J; 1974 Jan; 51(1):56-9. PubMed ID: 4839238
    [No Abstract]   [Full Text] [Related]  

  • 25. Combination chemotherapy: considerations for design and analysis.
    Lloyd HH
    Cancer Chemother Rep 2; 1974 Mar; 4(1):157-65. PubMed ID: 4826495
    [No Abstract]   [Full Text] [Related]  

  • 26. Heparin and cancer.
    Zacharski LR; Ornstein DL
    Thromb Haemost; 1998 Jul; 80(1):10-23. PubMed ID: 9684778
    [No Abstract]   [Full Text] [Related]  

  • 27. [Modern methods of therapeutic management of malignant proliferative disorders].
    Sroczyński J
    Wiad Lek; 1974 Nov; 27(22):1977-83. PubMed ID: 4613011
    [No Abstract]   [Full Text] [Related]  

  • 28. Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents.
    Corbett TH; Roberts BJ; Trader MW; Laster WR; Griswold DP; Schabel FM
    Cancer Treat Rep; 1982 May; 66(5):1187-200. PubMed ID: 7083221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing therapeutic potency of anticancer drugs in animal studies: a commentary.
    Den Otter W; Steerenberg PA; Van der Laan JW
    Regul Toxicol Pharmacol; 2002 Apr; 35(2 Pt 1):266-72. PubMed ID: 12052010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale for the use of alternating non-cross-resistant chemotherapy.
    Goldie JH; Coldman AJ; Gudauskas GA
    Cancer Treat Rep; 1982 Mar; 66(3):439-49. PubMed ID: 7060033
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental methodology for the selection of potential anticancer agents].
    Pérez Mínguez F; Llombart Bosch A
    Rev Esp Oncol; 1982; 29(4):593-602. PubMed ID: 6927364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statistical designs for experiments in combination therapy.
    Miller I
    Cancer Chemother Rep 2; 1974 Mar; 4(1):151-6. PubMed ID: 4826494
    [No Abstract]   [Full Text] [Related]  

  • 33. G-quadruplex ligand RHPS4 potentiates the antitumor activity of camptothecins in preclinical models of solid tumors.
    Leonetti C; Scarsella M; Riggio G; Rizzo A; Salvati E; D'Incalci M; Staszewsky L; Frapolli R; Stevens MF; Stoppacciaro A; Mottolese M; Antoniani B; Gilson E; Zupi G; Biroccio A
    Clin Cancer Res; 2008 Nov; 14(22):7284-91. PubMed ID: 19010844
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer.
    Gomez GG; Hutchison RB; Kruse CA
    Cancer Treat Rev; 2001 Dec; 27(6):375-402. PubMed ID: 11908930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental staphylococcal endocarditis: an overview.
    Gutschik E
    Scand J Infect Dis Suppl; 1983; 41():87-94. PubMed ID: 6589765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems (author's transl)].
    Nowak C; Arnold W; Henneberger G; Tanneberger S
    Arch Geschwulstforsch; 1980; 50(8):747-57. PubMed ID: 7224818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of 6-azauridine on plasma cell tumors of mice: correlation of antitumor effect with inhibition of orotic acid metabolism.
    Conn HO; Creasey WA; Calabresi P
    Cancer Res; 1967 Apr; 27(4):618-25. PubMed ID: 6071670
    [No Abstract]   [Full Text] [Related]  

  • 38. Medicine. Building better mouse models for studying cancer.
    Marx J
    Science; 2003 Mar; 299(5615):1972-5. PubMed ID: 12663895
    [No Abstract]   [Full Text] [Related]  

  • 39. [Means of enhancing treatment effectiveness in syphilis patients].
    Borisenko KK; Bednova VN; Nazarova AIu; Navolotskaia TI; Karimov KS
    Vestn Dermatol Venerol; 1988; (6):68-70. PubMed ID: 3176683
    [No Abstract]   [Full Text] [Related]  

  • 40. New leukemia drug shows promise against Gleevec resistance.
    Ashraf H
    Drug Discov Today; 2005 Apr; 10(7):453-4. PubMed ID: 15809187
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.